{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:59:39Z","timestamp":1785491979819,"version":"3.56.0"},"posted":{"date-parts":[[2026,7,31]]},"group-title":"In Review","reference-count":91,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,17]]},"abstract":"<title>Abstract<\/title>\n                <p>As the world's population ages, Alzheimer's disease (AD), a progressive neurodegenerative disorder, is becoming more common. The current diagnoses for AD are not precise enough to identify the disorder when it is possible to cure. An early indicator of Alzheimer's is the assessment of beta-amyloid by positron emission tomography (PET) score, a substantial decrease in the brain's metabolomics. Furthermore, Metabolomics can be detected by UPLC (ultra-high pressure liquid chromatography). This study investigates the link between metabolic profiles and beta-amyloid load in AD in order to shed light on possible biomarkers for disease progression. The data from 59 people who have been diagnosed with moderate cognitive impairment (MCI) is extracted from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). This study uses ultra-high-performance liquid chromatography (UPLC) to investigate the correlation between baseline metabolic data and changes in amyloid PET scores. Seven metabolites, including DOPA, Methionine Sulfoxide (Met.SO), Tryptophan Betaine, choline, leucine, valine, and FA (18:2), seem to have a substantial connection with amyloid PET scores. These can be used as early indications of AD progression, especially Met.SO is particularly relevant when considering time interaction. Understanding the metabolic alterations associated with amyloid load can pave the way for future research incorporating metabolites into a therapeutic treatment that can be identified as crucial to the illness\u2019s progression.<\/p>","DOI":"10.21203\/rs.3.rs-10065374\/v1","type":"posted-content","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:31:48Z","timestamp":1785490308000},"source":"Crossref","is-referenced-by-count":0,"title":["Determining the metabolic profile measured using ultra-high pressure liquid chromatography associated with Beta Amyloid burden in the brain in individuals with mild cognitive impairment"],"prefix":"10.21203","author":[{"given":"Marjan","family":"Falahati","sequence":"first","affiliation":[{"name":"Kermanshah University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Ramezannejad","sequence":"additional","affiliation":[{"name":"Isfahan University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosra","family":"Vaez-Gharamaleki","sequence":"additional","affiliation":[{"name":"Tabriz University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Radnia","sequence":"additional","affiliation":[{"name":"Tabriz University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Shahba","sequence":"additional","affiliation":[{"name":"Mashhad University of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Rasoulian","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Islamic Azad University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Dasmeh","sequence":"additional","affiliation":[{"name":"Iran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Bemanalizadeh","sequence":"additional","affiliation":[{"name":"Isfahan University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"."},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/bpa.12592","article-title":"Purine\u2010related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology","volume":"28","author":"Alonso-Andr\u00e9s P","year":"2018","unstructured":"Alonso-Andr\u00e9s, P., Albasanz, J. L., Ferrer, I. & Mart\u00edn, M. Purine\u2010related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology. Brain Pathol. 28 (6), 933\u2013946 (2018).","journal-title":"Brain Pathol."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"954090","DOI":"10.3389\/fnagi.2022.954090","article-title":"Plasma glycocholic acid and linoleic acid identified as potential mediators of mitochondrial bioenergetics in Alzheimer\u2019s dementia","volume":"14","author":"Amick KA","year":"2022","unstructured":"Amick, K. A. et al. Plasma glycocholic acid and linoleic acid identified as potential mediators of mitochondrial bioenergetics in Alzheimer\u2019s dementia. Front. Aging Neurosci. 14, 954090 (2022).","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"ref4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/bf02252924","article-title":"Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects","volume":"2","author":"Basun H","year":"1990","unstructured":"Basun, H. et al. Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects. J. Neural Transm Park Dis. Dement. Sect. 2 (4), 295\u2013304. 10.1007\/bf02252924 (1990).","journal-title":"J. Neural Transm Park Dis. Dement. Sect."},{"key":"ref5","author":"Battista P","year":"2017","unstructured":"Battista, P., Salvatore, C. & Castiglioni, I. Optimizing neuropsychological assessments for cognitive, behavioral, and functional impairment classification: a machine learning study. Behavioural neurology, 2017. (2017)."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2741\/4636","article-title":"Choline, the brain and neurodegeneration: Insights from epigenetics","volume":"23","author":"Bekdash R","year":"2018","unstructured":"Bekdash, R. Choline, the brain and neurodegeneration: Insights from epigenetics. Front. Biosci. 23, 1113\u20131143. 10.2741\/4636 (2018).","journal-title":"Front. Biosci."},{"issue":"12","key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/nu11122995","article-title":"Neuroprotective Effects of Choline and Other Methyl Donors","volume":"11","author":"Bekdash RA","year":"2019","unstructured":"Bekdash, R. A. Neuroprotective Effects of Choline and Other Methyl Donors. Nutrients 11 (12). 10.3390\/nu11122995 (2019).","journal-title":"Nutrients"},{"issue":"3","key":"ref8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3233\/jad-170680","article-title":"Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis","volume":"62","author":"Bjerke M","year":"2018","unstructured":"Bjerke, M. & Engelborghs, S. Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis. J. Alzheimers Dis. 62 (3), 1199\u20131209. 10.3233\/jad-170680 (2018).","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.archger.2008.07.005","article-title":"The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease","volume":"49","author":"Brugnolo A","year":"2009","unstructured":"Brugnolo, A. et al. The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. Arch. Gerontol. Geriatr. 49 (1), 180\u2013185 (2009).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnagi.2019.00269","article-title":"Is AD a stress-related disorder? Focus on the HPA axis and its promising therapeutic targets","volume":"11","author":"Canet G","year":"2019","unstructured":"Canet, G. et al. Is AD a stress-related disorder? Focus on the HPA axis and its promising therapeutic targets. Front. Aging Neurosci. 11, 269 (2019).","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13010021","article-title":"Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer's Disease","volume":"13","author":"Chandran S","year":"2023","unstructured":"Chandran, S. & Binninger, D. Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer's Disease. Antioxid. (Basel). 13 (1). 10.3390\/antiox13010021 (2023).","journal-title":"Antioxid. (Basel)"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","article-title":"Dopamine, Immunity, and Disease","volume":"75","author":"Channer B","year":"2023","unstructured":"Channer, B. et al. Dopamine, Immunity, and Disease. Pharmacol. Rev. 75 (1), 62\u2013158. 10.1124\/pharmrev.122.000618 (2023).","journal-title":"Pharmacol. Rev."},{"key":"ref13","first-page":"1","article-title":"Redox signaling and Alzheimer\u2019s disease: from pathomechanism insights to biomarker discovery and therapy strategy","volume":"8","author":"Chen YY","year":"2020","unstructured":"Chen, Y. Y. et al. Redox signaling and Alzheimer\u2019s disease: from pathomechanism insights to biomarker discovery and therapy strategy. Biomark. Res. 8, 1\u201313 (2020).","journal-title":"Biomark. Res."},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","article-title":"Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias","volume":"19","author":"Ch\u00e9telat G","year":"2020","unstructured":"Ch\u00e9telat, G. et al. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. Lancet Neurol. 19 (11), 951\u2013962 (2020).","journal-title":"Lancet Neurol."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"539026","DOI":"10.3389\/fphys.2020.00598","article-title":"Involvement of lipids in Alzheimer\u2019s disease pathology and potential therapies","volume":"11","author":"Chew H","year":"2020","unstructured":"Chew, H., Solomon, V. A. & Fonteh, A. N. Involvement of lipids in Alzheimer\u2019s disease pathology and potential therapies. Front. Physiol. 11, 539026 (2020).","journal-title":"Front. Physiol."},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jalz.2017.04.009","article-title":"Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study","volume":"13","author":"Chouraki V","year":"2017","unstructured":"Chouraki, V. et al. Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study. Alzheimer's Dement. 13 (12), 1327\u20131336 (2017).","journal-title":"Alzheimer's Dement."},{"issue":"1","key":"ref17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13311-016-0481-z","article-title":"Biomarkers for the Early Detection and Progression of Alzheimer's Disease","volume":"14","author":"Counts SE","year":"2017","unstructured":"Counts, S. E., Ikonomovic, M. D., Mercado, N., Vega, I. E. & Mufson, E. J. Biomarkers for the Early Detection and Progression of Alzheimer's Disease. Neurotherapeutics 14 (1), 35\u201353. 10.1007\/s13311-016-0481-z (2017).","journal-title":"Neurotherapeutics"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-2012-110629","article-title":"Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease","volume":"29","author":"Cunnane SC","year":"2012","unstructured":"Cunnane, S. C. et al. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J. Alzheimers Dis. 29 (3), 691\u2013697 (2012).","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031501","article-title":"Metabolite profiling of Alzheimer's disease cerebrospinal fluid","volume":"7","author":"Czech C","year":"2012","unstructured":"Czech, C. et al. Metabolite profiling of Alzheimer's disease cerebrospinal fluid. PloS one, 7(2), e31501. (2012).","journal-title":"PloS one"},{"issue":"2","key":"ref20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/alz.12180","article-title":"Circulating metabolites are associated with brain atrophy and white matter hyperintensities","volume":"17","author":"Leeuw FA","year":"2021","unstructured":"de Leeuw, F. A. et al. Circulating metabolites are associated with brain atrophy and white matter hyperintensities. Alzheimers Dement. 17 (2), 205\u2013214. 10.1002\/alz.12180 (2021).","journal-title":"Alzheimers Dement."},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0167-4943(88)90029-5","article-title":"Purine metabolites in the CSF in presenile and senile dementia of Alzheimer type, and in multi infarct dementia","volume":"7","author":"Degrell I","year":"1988","unstructured":"Degrell, I. & Niklasson, F. Purine metabolites in the CSF in presenile and senile dementia of Alzheimer type, and in multi infarct dementia. Arch. Gerontol. Geriatr. 7 (2), 173\u2013178 (1988).","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"7\u201308","key":"ref22","first-page":"29","article-title":"Increased Levels of Protein-methionine Sulfoxide in Plasma Correlate with a Shift from a Mild Cognitive Impairment to an Alzheimer's Disease Stage","volume":"16","author":"Deng Y","year":"2019","unstructured":"Deng, Y., Marsh, B. M. & Moskovitz, J. Increased Levels of Protein-methionine Sulfoxide in Plasma Correlate with a Shift from a Mild Cognitive Impairment to an Alzheimer's Disease Stage. Innov. Clin. Neurosci. 16 (7\u201308), 29\u201331 (2019).","journal-title":"Innov. Clin. Neurosci."},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archpsyc.64.12.1443","article-title":"Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment","volume":"64","author":"Dickerson BC","year":"2007","unstructured":"Dickerson, B. C., Sperling, R. A., Hyman, B. T., Albert, M. S. & Blacker, D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch. Gen. Psychiatry. 64 (12), 1443\u20131450 (2007).","journal-title":"Arch. Gen. Psychiatry"},{"issue":"39","key":"ref24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3238\/arztebl.2010.0677","article-title":"New developments in the diagnosis of dementia","volume":"107","author":"Eschweiler GW","year":"2010","unstructured":"Eschweiler, G. W., Leyhe, T., Kl\u00f6ppel, S. & H\u00fcll, M. New developments in the diagnosis of dementia. Dtsch. Arztebl Int. 107 (39), 677\u2013683. 10.3238\/arztebl.2010.0677 (2010).","journal-title":"Dtsch. Arztebl Int."},{"issue":"1","key":"ref25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159x13666150716165726","article-title":"Alzheimer's disease: Targeting the Cholinergic System","volume":"14","author":"Ferreira-Vieira TH","year":"2016","unstructured":"Ferreira-Vieira, T. H., Guimaraes, I. M., Silva, F. R. & Ribeiro, F. M. Alzheimer's disease: Targeting the Cholinergic System. Curr. Neuropharmacol. 14 (1), 101\u2013115. 10.2174\/1570159x13666150716165726 (2016).","journal-title":"Curr. Neuropharmacol."},{"issue":"11 Suppl 18","key":"ref26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1017\/s1092852900014164","article-title":"The interplay of neurotransmitters in Alzheimer's disease","volume":"10","author":"Francis PT","year":"2005","unstructured":"Francis, P. T. The interplay of neurotransmitters in Alzheimer's disease. CNS Spectr. 10 (11 Suppl 18), 6\u20139. 10.1017\/s1092852900014164 (2005).","journal-title":"CNS Spectr."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","article-title":"Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease","volume":"107","author":"Gonz\u00e1lez-Dom\u00ednguez R","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez, R., Garc\u00eda-Barrera, T. & G\u00f3mez-Ariza, J. L. Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease. J. Pharm. Biomed. Anal. 107, 75\u201381 (2015).","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"ref28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/s1474-4422(20)30440-3","article-title":"New insights into atypical Alzheimer's disease in the era of biomarkers","volume":"20","author":"Graff-Radford J","year":"2021","unstructured":"Graff-Radford, J. et al. New insights into atypical Alzheimer's disease in the era of biomarkers. Lancet Neurol. 20 (3), 222\u2013234. 10.1016\/s1474-4422(20)30440-3 (2021).","journal-title":"Lancet Neurol."},{"issue":"1","key":"ref29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13195-023-01184-y","article-title":"Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease","volume":"15","author":"Green RE","year":"2023","unstructured":"Green, R. E. et al. Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease. Alzheimers Res. Ther. 15 (1), 38. 10.1186\/s13195-023-01184-y (2023).","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"ref30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41398-022-01901-5","article-title":"Cerebrospinal fluid catecholamines in Alzheimer's disease patients with and without biological disease","volume":"12","author":"Henjum K","year":"2022","unstructured":"Henjum, K. et al. Cerebrospinal fluid catecholamines in Alzheimer's disease patients with and without biological disease. Transl Psychiatry. 12 (1), 151. 10.1038\/s41398-022-01901-5 (2022).","journal-title":"Transl Psychiatry"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2022-000344","article-title":"Cortisol, cognition and Alzheimer\u2019s disease biomarkers among memory clinic patients","volume":"4","author":"Holleman J","year":"2022","unstructured":"Holleman, J. et al. Cortisol, cognition and Alzheimer\u2019s disease biomarkers among memory clinic patients. BMJ Neurol. Open, 4(2). (2022).","journal-title":"BMJ Neurol. Open"},{"key":"ref32","unstructured":"http:\/\/scikitlearn.org\/stable\/modules\/generated\/sklearn.feature_selection.f_regression.hml"},{"key":"ref33","unstructured":"https:\/\/bmcbiochem.biomedcentral.com\/articles\/10.1186\/1471-2091-13-21"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes CP","year":"1982","unstructured":"Hughes, C. P., Berg, L., Danziger, W., Coben, L. A. & Martin, R. L. A new clinical scale for the staging of dementia. Br. J. psychiatry. 140 (6), 566\u2013572 (1982).","journal-title":"Br. J. psychiatry"},{"issue":"20","key":"ref35","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1021\/ac301243k","article-title":"Toward a predictive model of Alzheimer\u2019s disease progression using capillary electrophoresis\u2013mass spectrometry metabolomics","volume":"84","author":"Ib\u00e1\u00f1ez C","year":"2012","unstructured":"Ib\u00e1\u00f1ez, C. et al. Toward a predictive model of Alzheimer\u2019s disease progression using capillary electrophoresis\u2013mass spectrometry metabolomics. Anal. Chem. 84 (20), 8532\u20138540 (2012).","journal-title":"Anal. Chem."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1040476","DOI":"10.3389\/fnut.2022.1040476","article-title":"Decreased circulating branched-chain amino acids are associated with development of Alzheimer\u2019s disease in elderly individuals with mild cognitive impairment","volume":"9","author":"Ikeuchi T","year":"2022","unstructured":"Ikeuchi, T. et al. Decreased circulating branched-chain amino acids are associated with development of Alzheimer\u2019s disease in elderly individuals with mild cognitive impairment. Front. Nutr. 9, 1040476 (2022).","journal-title":"Front. Nutr."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation","volume":"132","author":"Innes JK","year":"2018","unstructured":"Innes, J. K. & Calder, P. C. Omega-6 fatty acids and inflammation. Prostaglandins, Leukot. Essent. Fatty Acids. 132, 41\u201348 (2018).","journal-title":"Prostaglandins, Leukot. Essent. Fatty Acids"},{"issue":"11","key":"ref38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust W","year":"2018","unstructured":"Jagust, W. Imaging the evolution and pathophysiology of Alzheimer disease. Nat. Rev. Neurosci. 19 (11), 687\u2013700. 10.1038\/s41583-018-0067-3 (2018).","journal-title":"Nat. Rev. Neurosci."},{"issue":"19","key":"ref39","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1021\/acschemneuro.2c00484","article-title":"Impaired Dopamine Release and Latent Learning in Alzheimer's Disease Model Zebrafish","volume":"13","author":"Jarosova R","year":"2022","unstructured":"Jarosova, R., Niyangoda, S. S., Hettiarachchi, P. & Johnson, M. A. Impaired Dopamine Release and Latent Learning in Alzheimer's Disease Model Zebrafish. ACS Chem. Neurosci. 13 (19), 2924\u20132931. 10.1021\/acschemneuro.2c00484 (2022).","journal-title":"ACS Chem. Neurosci."},{"issue":"9","key":"ref40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/antiox7090122","article-title":"The functions of the mammalian methionine sulfoxide reductase system and related diseases","volume":"7","author":"Jiang B","year":"2018","unstructured":"Jiang, B. & Moskovitz, J. The functions of the mammalian methionine sulfoxide reductase system and related diseases. Antioxidants 7 (9), 122 (2018).","journal-title":"Antioxidants"},{"issue":"4","key":"ref41","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00401-023-02616-7","article-title":"Inflammation and the pathological progression of Alzheimer's disease are associated with low circulating choline levels","volume":"146","author":"Judd JM","year":"2023","unstructured":"Judd, J. M. et al. Inflammation and the pathological progression of Alzheimer's disease are associated with low circulating choline levels. Acta Neuropathol. 146 (4), 565\u2013583. 10.1007\/s00401-023-02616-7 (2023).","journal-title":"Acta Neuropathol."},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/antiox10091439","article-title":"Chronic stress and oxidative stress as common factors of the pathogenesis of depression and Alzheimer\u2019s disease: The role of antioxidants in prevention and treatment","volume":"10","author":"Juszczyk G","year":"2021","unstructured":"Juszczyk, G. et al. Chronic stress and oxidative stress as common factors of the pathogenesis of depression and Alzheimer\u2019s disease: The role of antioxidants in prevention and treatment. Antioxidants 10 (9), 1439 (2021).","journal-title":"Antioxidants"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1038\/tp.2013.18","article-title":"Alterations in metabolic pathways and networks in Alzheimer\u2019s disease","volume":"3","author":"Kaddurah-Daouk R","year":"2013","unstructured":"Kaddurah-Daouk, R. et al. Alterations in metabolic pathways and networks in Alzheimer\u2019s disease. Translational psychiatry. 3 (4), e244\u2013e244 (2013).","journal-title":"Translational psychiatry"},{"issue":"11","key":"ref44","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1570159x18666200528142429","article-title":"Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease","volume":"18","author":"Khan S","year":"2020","unstructured":"Khan, S., Barve, K. H. & Kumar, M. S. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease. Curr. Neuropharmacol. 18 (11), 1106\u20131125. 10.2174\/1570159x18666200528142429 (2020).","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"ref45","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jalz.2019.03.004","article-title":"Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort","volume":"15","author":"Kim M","year":"2019","unstructured":"Kim, M. et al. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort. Alzheimers Dement. 15 (6), 817\u2013827. 10.1016\/j.jalz.2019.03.004 (2019).","journal-title":"Alzheimers Dement."},{"issue":"11","key":"ref46","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1038\/npp.2014.119","article-title":"Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients","volume":"39","author":"Koch G","year":"2014","unstructured":"Koch, G. et al. Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients. Neuropsychopharmacology 39 (11), 2654\u20132661. 10.1038\/npp.2014.119 (2014).","journal-title":"Neuropsychopharmacology"},{"issue":"13","key":"ref47","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.3390\/ijms241310717","article-title":"DHA\/EPA (Omega-3) and LA\/GLA (Omega-6) as bioactive molecules in neurodegenerative diseases","volume":"24","author":"Kousparou C","year":"2023","unstructured":"Kousparou, C., Fyrilla, M., Stephanou, A. & Patrikios, I. DHA\/EPA (Omega-3) and LA\/GLA (Omega-6) as bioactive molecules in neurodegenerative diseases. Int. J. Mol. Sci. 24 (13), 10717 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1038\/s41598-017-12931-1","article-title":"Branched-chain amino acids and Alzheimer\u2019s disease: a Mendelian randomization analysis","volume":"7","author":"Larsson SC","year":"2017","unstructured":"Larsson, S. C. & Markus, H. S. Branched-chain amino acids and Alzheimer\u2019s disease: a Mendelian randomization analysis. Sci. Rep. 7 (1), 13604 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010129","article-title":"Mechanistic Link between Vitamin B12 and Alzheimer's Disease","volume":"12","author":"Lauer AA","year":"2022","unstructured":"Lauer, A. A. et al. Mechanistic Link between Vitamin B12 and Alzheimer's Disease. Biomolecules 12 (1). 10.3390\/biom12010129 (2022).","journal-title":"Biomolecules"},{"issue":"2","key":"ref50","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/joim.13244","article-title":"Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis","volume":"290","author":"Liss JL","year":"2021","unstructured":"Liss, J. L. et al. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis. J. Intern. Med. 290 (2), 310\u2013334. 10.1111\/joim.13244 (2021).","journal-title":"J. Intern. Med."},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"e1003012","DOI":"10.1371\/journal.pmed.1003012","article-title":"Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study","volume":"17","author":"Mahajan UV","year":"2020","unstructured":"Mahajan, U. V. et al. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study. PLoS Med. 17 (1), e1003012 (2020).","journal-title":"PLoS Med."},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/alz.12731","article-title":"Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease","volume":"19","author":"Mahapatra G","year":"2023","unstructured":"Mahapatra, G. et al. Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease. Alzheimer's Dement. 19 (4), 1466\u20131478 (2023).","journal-title":"Alzheimer's Dement."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14283\/jpad.2020.73","article-title":"Psychometric properties of the Clinical Dementia Rating\u2014Sum of Boxes and other cognitive and functional outcomes in a prodromal Alzheimer\u2019s disease population","volume":"8","author":"McDougall F","year":"2021","unstructured":"McDougall, F. et al. Psychometric properties of the Clinical Dementia Rating\u2014Sum of Boxes and other cognitive and functional outcomes in a prodromal Alzheimer\u2019s disease population. J. Prev. Alzheimer's Disease. 8, 151\u2013160 (2021).","journal-title":"J. Prev. Alzheimer's Disease"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope","volume":"11","author":"Mohs RC","year":"1997","unstructured":"Mohs, R. C. et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. Alzheimer Disease Assoc. Disorders. 11, 13\u201321 (1997).","journal-title":"Alzheimer Disease Assoc. Disorders"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nbd.2013.12.017","article-title":"Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease","volume":"65","author":"Morabito MV","year":"2014","unstructured":"Morabito, M. V. et al. Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease. Neurobiol. Dis. 65, 188\u2013192 (2014).","journal-title":"Neurobiol. Dis."},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00122","article-title":"Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-\u03b2 Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease","volume":"9","author":"Nam E","year":"2018","unstructured":"Nam, E. et al. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-\u03b2 Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease. ACS Chem. Neurosci. 9 10.1021\/acschemneuro.8b00122 (2018).","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"ref57","doi-asserted-by":"publisher","first-page":"fcab139","DOI":"10.1093\/braincomms\/fcab139","article-title":"Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression","volume":"3","author":"Nho K","year":"2021","unstructured":"Nho, K. et al. Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression. Brain Commun. 3 (3), fcab139. 10.1093\/braincomms\/fcab139 (2021).","journal-title":"Brain Commun."},{"issue":"5","key":"ref58","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/alz.12800","article-title":"Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains","volume":"19","author":"Novotny BC","year":"2023","unstructured":"Novotny, B. C. et al. Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains. Alzheimers Dement. 19 (5), 1785\u20131799. 10.1002\/alz.12800 (2023).","journal-title":"Alzheimers Dement."},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-142925","article-title":"A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease","volume":"45","author":"Olazar\u00e1n J","year":"2015","unstructured":"Olazar\u00e1n, J. et al. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease. J. Alzheimers Dis. 45 (4), 1157\u20131173 (2015).","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JAD-131892","article-title":"Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls","volume":"41","author":"Olde Rikkert MG","year":"2014","unstructured":"Olde Rikkert, M. G. et al. Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls. J. Alzheimers Dis. 41 (1), 261\u2013271 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","article-title":"Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis","volume":"11","author":"Pan X","year":"2019","unstructured":"Pan, X. et al. Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis. Front. Aging Neurosci. 11, 175. 10.3389\/fnagi.2019.00175 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cca.2019.10.023","article-title":"Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility","volume":"500","author":"Pe\u00f1a-Bautista C","year":"2020","unstructured":"Pe\u00f1a-Bautista, C. et al. Plasma alterations in cholinergic and serotonergic systems in early Alzheimer Disease: Diagnosis utility. Clin. Chim. Acta. 500, 233\u2013240. 10.1016\/j.cca.2019.10.023 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0170-5","article-title":"Alzheimer\u2019s Disease Assessment Scale\u2013Cognitive subscale variants in mild cognitive impairment and mild Alzheimer\u2019s disease: change over time and the effect of enrichment strategies","volume":"8","author":"Podhorna J","year":"2016","unstructured":"Podhorna, J., Krahnke, T., Shear, M., Harrison, E., Initiative, A. D. N. & J., & Alzheimer\u2019s Disease Assessment Scale\u2013Cognitive subscale variants in mild cognitive impairment and mild Alzheimer\u2019s disease: change over time and the effect of enrichment strategies. Alzheimers Res. Ther. 8, 1\u201313 (2016).","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"ref64","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jalz.2016.08.003","article-title":"Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis","volume":"13","author":"Proitsi P","year":"2017","unstructured":"Proitsi, P. et al. Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis. Alzheimers Dement. 13 (2), 140\u2013151. 10.1016\/j.jalz.2016.08.003 (2017).","journal-title":"Alzheimers Dement."},{"key":"ref65","author":"Qian X","year":"2023","unstructured":"Qian, X. et al. d. Investigating the causal association between branched-chain amino acids and Alzheimer's disease: A bidirectional Mendelian randomized study. Frontiers in Nutrition, 10, 1103303. (2023)."},{"issue":"10","key":"ref66","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/gps.2640","article-title":"PET imaging of brain amyloid in dementia: a review","volume":"26","author":"Quigley H","year":"2011","unstructured":"Quigley, H., Colloby, S. J. & O'Brien, J. T. PET imaging of brain amyloid in dementia: a review. Int. J. Geriatr. Psychiatry. 26 (10), 991\u2013999 (2011).","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"ref67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1358\/dot.2003.39.1.740206","article-title":"The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease","volume":"39","author":"Rees TM","year":"2003","unstructured":"Rees, T. M. & Brimijoin, S. The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease. Drugs Today (Barc). 39 (1), 75\u201383. 10.1358\/dot.2003.39.1.740206 (2003).","journal-title":"Drugs Today (Barc)"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/nu13020284","article-title":"Consumption of oleic acid on the preservation of cognitive functions in Japanese elderly individuals","volume":"13","author":"Sakurai K","year":"2021","unstructured":"Sakurai, K., Shen, C., Shiraishi, I., Inamura, N. & Hisatsune, T. Consumption of oleic acid on the preservation of cognitive functions in Japanese elderly individuals. Nutrients 13 (2), 284 (2021).","journal-title":"Nutrients"},{"issue":"1","key":"ref69","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/nu15010224","article-title":"Update on anti-inflammatory molecular mechanisms induced by oleic acid","volume":"15","author":"Santa-Mar\u00eda C","year":"2023","unstructured":"Santa-Mar\u00eda, C. et al. Update on anti-inflammatory molecular mechanisms induced by oleic acid. Nutrients 15 (1), 224 (2023).","journal-title":"Nutrients"},{"issue":"2","key":"ref70","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1590\/s1980-5764-2016dn1002003","article-title":"Imaging Alzheimer's disease pathophysiology with PET","volume":"10","author":"Schilling LP","year":"2016","unstructured":"Schilling, L. P. et al. Imaging Alzheimer's disease pathophysiology with PET. Dement. Neuropsychol. 10 (2), 79\u201390. 10.1590\/s1980-5764-2016dn1002003 (2016).","journal-title":"Dement. Neuropsychol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1292858","DOI":"10.3389\/fncel.2023.1292858","article-title":"Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease","volume":"17","author":"Shaikh A","year":"2023","unstructured":"Shaikh, A., Ahmad, F., Teoh, S. L., Kumar, J. & Yahaya, M. F. Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease. Front. Cell. Neurosci. 17, 1292858. 10.3389\/fncel.2023.1292858 (2023).","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"ref72","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.14336\/AD.2020.0217","article-title":"Alteration of metabolic profile and potential biomarkers in the plasma of Alzheimer\u2019s disease","volume":"11","author":"Shao Y","year":"2020","unstructured":"Shao, Y. et al. Alteration of metabolic profile and potential biomarkers in the plasma of Alzheimer\u2019s disease. Aging disease. 11 (6), 1459 (2020).","journal-title":"Aging disease"},{"issue":"21","key":"ref73","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.3390\/cells11213523","article-title":"Branched-chain amino acids are linked with Alzheimer\u2019s disease-related pathology and cognitive deficits","volume":"11","author":"Siddik MAB","year":"2022","unstructured":"Siddik, M. A. B. et al. Branched-chain amino acids are linked with Alzheimer\u2019s disease-related pathology and cognitive deficits. Cells 11 (21), 3523 (2022).","journal-title":"Cells"},{"issue":"4","key":"ref74","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11040775","article-title":"Protective Effects against the Development of Alzheimer's Disease in an Animal Model through Active Immunization with Methionine-Sulfoxide Rich Protein Antigen","volume":"11","author":"Smith AS","year":"2022","unstructured":"Smith, A. S., Gossman, K. R., Dykstra, B., Gao, F. P. & Moskovitz, J. Protective Effects against the Development of Alzheimer's Disease in an Animal Model through Active Immunization with Methionine-Sulfoxide Rich Protein Antigen. Antioxid. (Basel). 11 (4). 10.3390\/antiox11040775 (2022).","journal-title":"Antioxid. (Basel)"},{"issue":"3","key":"ref75","doi-asserted-by":"crossref","first-page":"e1002266","DOI":"10.1371\/journal.pmed.1002266","article-title":"Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study","volume":"14","author":"Snowden SG","year":"2017","unstructured":"Snowden, S. G. et al. Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study. PLoS Med. 14 (3), e1002266 (2017).","journal-title":"PLoS Med."},{"issue":"2","key":"ref76","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10433-013-0258-8","article-title":"Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and Development","volume":"10","author":"Stafford M","year":"2013","unstructured":"Stafford, M. et al. Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and Development. Eur. J. Ageing. 10 (2), 145\u2013157. 10.1007\/s10433-013-0258-8 (2013).","journal-title":"Eur. J. Ageing"},{"issue":"9","key":"ref77","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","article-title":"Metabolic network failures in Alzheimer's disease: A biochemical road map","volume":"13","author":"Toledo JB","year":"2017","unstructured":"Toledo, J. B. et al. Metabolic network failures in Alzheimer's disease: A biochemical road map. Alzheimer's Dement. 13 (9), 965\u2013984 (2017).","journal-title":"Alzheimer's Dement."},{"issue":"9","key":"ref78","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","article-title":"Metabolic network failures in Alzheimer's disease: A biochemical road map","volume":"13","author":"Toledo JB","year":"2017","unstructured":"Toledo, J. B. et al. Metabolic network failures in Alzheimer's disease: A biochemical road map. Alzheimers Dement. 13 (9), 965\u2013984. 10.1016\/j.jalz.2017.01.020 (2017).","journal-title":"Alzheimers Dement."},{"issue":"6","key":"ref79","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jalz.2018.01.003","article-title":"Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: a prospective study in eight cohorts","volume":"14","author":"Tynkkynen J","year":"2018","unstructured":"Tynkkynen, J. et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: a prospective study in eight cohorts. Alzheimer's Dement. 14 (6), 723\u2013733 (2018).","journal-title":"Alzheimer's Dement."},{"issue":"7","key":"ref80","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamainternmed.2015.1668","article-title":"Mediterranean diet and age-related cognitive decline: a randomized clinical trial","volume":"175","author":"Valls-Pedret C","year":"2015","unstructured":"Valls-Pedret, C. et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern. Med. 175 (7), 1094\u20131103 (2015).","journal-title":"JAMA Intern. Med."},{"issue":"17","key":"ref81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179290","article-title":"Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis","volume":"22","author":"Walczak-Nowicka \u0141","year":"2021","unstructured":"Walczak-Nowicka, \u0141., Herbet, M. & J., & Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis. Int. J. Mol. Sci. 22 (17). 10.3390\/ijms22179290 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"ref82","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.neurobiolaging.2010.09.013","article-title":"Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease","volume":"33","author":"Wang DC","year":"2012","unstructured":"Wang, D. C. et al. Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. Neurobiol. Aging. 33 (6), 1057\u20131066 (2012).","journal-title":"Neurobiol. Aging"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.01223","article-title":"The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment","volume":"10","author":"Weng WC","year":"2019a","unstructured":"Weng, W. C., Huang, W. Y., Tang, H. Y., Cheng, M. L. & Chen, K. H. The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment. Front. Neurol. 10 10.3389\/fneur.2019.01223 (2019a).","journal-title":"Front. Neurol."},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fneur.2019.01223","article-title":"The differences of serum metabolites between patients with early-stage Alzheimer's disease and mild cognitive impairment","volume":"10","author":"Weng WC","year":"2019","unstructured":"Weng, W. C., Huang, W. Y., Tang, H. Y., Cheng, M. L. & Chen, K. H. The differences of serum metabolites between patients with early-stage Alzheimer's disease and mild cognitive impairment. Front. Neurol. 10, 1223 (2019b).","journal-title":"Front. Neurol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3389\/fneur.2019.01223","article-title":"The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment","volume":"10","author":"Weng WC","year":"2019","unstructured":"Weng, W. C., Huang, W. Y., Tang, H. Y., Cheng, M. L. & Chen, K. H. The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment. Front. Neurol. 10, 1223. 10.3389\/fneur.2019.01223 (2019).","journal-title":"Front. Neurol."},{"issue":"8","key":"ref86","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s40520-022-02120-0","article-title":"The associations of serum valine with mild cognitive impairment and Alzheimer\u2019s disease","volume":"34","author":"Xiong Y","year":"2022","unstructured":"Xiong, Y. et al. The associations of serum valine with mild cognitive impairment and Alzheimer\u2019s disease. Aging Clin. Exp. Res. 34 (8), 1807\u20131817 (2022). s. D. N.","journal-title":"Aging Clin. Exp. Res."},{"issue":"1","key":"ref87","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-020-00215-0","article-title":"Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease","volume":"9","author":"Xu J","year":"2020","unstructured":"Xu, J. et al. Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's disease. Transl Neurodegener. 9 (1), 36. 10.1186\/s40035-020-00215-0 (2020).","journal-title":"Transl Neurodegener"},{"key":"ref88","author":"Xu J","year":"2021","unstructured":"Xu, J. et al. Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort. Biomedicines 9 (11). 10.3390\/biomedicines9111610 (2021). On Behalf Of The European Medical Information Framework."},{"issue":"6","key":"ref89","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin F","year":"2023","unstructured":"Yin, F. Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J. 290 (6), 1420\u20131453 (2023).","journal-title":"FEBS J."},{"key":"ref90","doi-asserted-by":"crossref","first-page":"101171","DOI":"10.1016\/j.arr.2020.101171","article-title":"Cortisol hypersecretion and the risk of Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"64","author":"Zheng B","year":"2020","unstructured":"Zheng, B., Tal, R., Yang, Z., Middleton, L. & Udeh-Momoh, C. Cortisol hypersecretion and the risk of Alzheimer\u2019s disease: A systematic review and meta-analysis. Ageing Res. Rev. 64, 101171 (2020).","journal-title":"Ageing Res. Rev."},{"key":"ref91","author":"Table","unstructured":"Table 1- Biochemical classes of metabolites included in this study."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10065374\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10065374\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:32:00Z","timestamp":1785490320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10065374\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":91,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10065374\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,7,31]]},"subtype":"preprint"}}